An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety

Objective. To assess the effectiveness, drug survival and safety of tocilizumab compared with TNF-α inhibitors in clinical practice. Methods. Patients in the Cohort of Arthritis Biologic Users at Kameda Institute (CABUKI) registry who were on biologics during July 2003 to October 2010 were included....

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kazuki, Tokuda, Yasuharu, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A., Matsui, Kazuo, Kishimoto, Mitsumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198907/
https://www.ncbi.nlm.nih.gov/pubmed/21890622
http://dx.doi.org/10.1093/rheumatology/ker295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198907/
https://www.ncbi.nlm.nih.gov/pubmed/21890622
http://dx.doi.org/10.1093/rheumatology/ker295

Ejemplares similares